These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 18989524)
41. Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation. Bui HT; Krisnaswami A; Le CU; Chan J; Shenoy BN Am J Cardiol; 2009 Nov; 104(10):1429-33. PubMed ID: 19892063 [TBL] [Abstract][Full Text] [Related]
42. Clinically significant differences between point-of-care analysers and a standard analyser for monitoring the International Normalized Ratio in oral anticoagulant therapy: a multi-instrument evaluation in a hospital outpatient setting. Moore GW; Henley A; Cotton SS; Tugnait S; Rangarajan S Blood Coagul Fibrinolysis; 2007 Apr; 18(3):287-92. PubMed ID: 17413768 [TBL] [Abstract][Full Text] [Related]
43. Prospective echocardiographic evaluation of patients with endogenous subclinical hyperthyroidism and after restoring euthyroidism. Kaminski G; Michalkiewicz D; Makowski K; Podgajny Z; Szalus N; Ruchala M; Szczepanek E; Gielerak G Clin Endocrinol (Oxf); 2011 Apr; 74(4):501-7. PubMed ID: 21158893 [TBL] [Abstract][Full Text] [Related]
44. Atmospheric pressure changes and unexplained variability in INR measurements. Ernst ME; Shaw RF; Ernst EJ; Alexander B; Kaboli PJ Blood Coagul Fibrinolysis; 2009 Jun; 20(4):263-70. PubMed ID: 19300239 [TBL] [Abstract][Full Text] [Related]
46. Challenge of coadministering antiretroviral therapy and oral anticoagulants in HIV-positive patients. Goldstein KM; Gluckman S; Mounzer K AIDS Read; 2008 Sep; 18(9):480-2, 486-9. PubMed ID: 18828233 [TBL] [Abstract][Full Text] [Related]
47. Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin. Wieloch M; Hillarp A; Strandberg K; Nilsson C; Svensson PJ Thromb Res; 2009 Jul; 124(3):344-8. PubMed ID: 19423152 [TBL] [Abstract][Full Text] [Related]
49. Possible effect of thyroid function on anticoagulant response to unfractionated heparin. Badawi O Pharmacotherapy; 2006 Feb; 26(2):285-8. PubMed ID: 16466335 [TBL] [Abstract][Full Text] [Related]
50. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study. Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184 [TBL] [Abstract][Full Text] [Related]
51. Prolonged anticoagulation therapy adjunctive to aspirin after successful fibrinolysis: from early reduction in reocclusion to improved long-term clinical outcome. van den Bergh PJ; Kievit PC; Brouwer MA; Aengevaeren WR; Veen G; Verheugt FW Am Heart J; 2009 Mar; 157(3):532-40. PubMed ID: 19249425 [TBL] [Abstract][Full Text] [Related]
52. Establishing an oral anticoagulant monitoring service in a multiethnic developing country. Casimire T; Carter R; Peters S; Tweedle J; Charles KS Int J Lab Hematol; 2008 Dec; 30(6):531-5. PubMed ID: 18983306 [TBL] [Abstract][Full Text] [Related]
53. Interaction between gemfibrozil and warfarin: case report and review of the literature. Dixon DL; Williams VG Pharmacotherapy; 2009 Jun; 29(6):744-8. PubMed ID: 19476425 [TBL] [Abstract][Full Text] [Related]
54. Warfarin anticoagulation intensity in specialist-based and in computer-assisted dosing practice. Onundarson PT; Einarsdottir KA; Gudmundsdottir BR Int J Lab Hematol; 2008 Oct; 30(5):382-9. PubMed ID: 19046313 [TBL] [Abstract][Full Text] [Related]
55. Atrial fibrillation ablation in patients with therapeutic international normalized ratios. Schmidt M; Segerson NM; Marschang H; Akoum N; Rittger H; Clifford SM; Brachmann J; Daccarett M; Marrouche NF Pacing Clin Electrophysiol; 2009 Aug; 32(8):995-9. PubMed ID: 19659617 [TBL] [Abstract][Full Text] [Related]
57. International normalized ratio patient self-management for mechanical valves: is it safe enough? Koerfer R; Reiss N; Koertke H Curr Opin Cardiol; 2009 Mar; 24(2):130-5. PubMed ID: 19532098 [TBL] [Abstract][Full Text] [Related]
58. Self-management program improves anticoagulation control and quality of life: a prospective randomized study. Soliman Hamad MA; van Eekelen E; van Agt T; van Straten AH Eur J Cardiothorac Surg; 2009 Feb; 35(2):265-9. PubMed ID: 19041254 [TBL] [Abstract][Full Text] [Related]
59. Relationship between chromogenic factor X and international normalized ratio differs during early warfarin initiation compared with chronic warfarin administration. Rosborough TK; Jacobsen JM; Shepherd MF Blood Coagul Fibrinolysis; 2009 Sep; 20(6):433-5. PubMed ID: 19543077 [TBL] [Abstract][Full Text] [Related]
60. Clot lifespan model analysis of the effects of warfarin on thrombus growth and fibrinolysis: role of contact protein and tissue factor initiation. Nielsen VG; Kirklin JK; Holman WL; Steenwyk BL ASAIO J; 2009; 55(1):33-40. PubMed ID: 19092656 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]